While I can't speak for any individual company, the basic answer is yes. I'll come back to CEPA framework; it's expecting you to do that. We deal with our existing substances, those that were in commerce before CEPA provisions went in for new substance notification. We had a list of these substances. If the government says there's a problem here, it has to be managed. Obviously one way to manage that is to look for alternatives. If you can do that, that's great.
When you look at substances on the list and you want to propose a new activity for a substance, you have to request a significant new activity process through the government. The burden is on you to demonstrate again that the substance you're proposing to use in that activity is indeed safe for human health and the environment. Then you have your brand new substances, where you have to go through a whole new substance notification process.
The basis premise is that if you've gone through the significant new activity or the new substance notification process, the decision-making is that the substance is acceptably safe for use for your intended application, and that application only, and poses no significant risk of harm to human health and the environment. The process is there.
I'll say it again: CEPA works incredibly well. I would encourage you, perhaps as part of your examination, to look at some of the studies by the U.S. government and U.S. academics that are influencing the direction they are taking on their Toxic Substances Control Act. You will be very proud of the degree to which you see Canada's CMP approach reflected in there. It works. It manages hazards very effectively, and puts public and private resources directly focused on the areas that pose the highest risk to human health and the environment.